Chemical potential in active systems: predicting phase equilibrium from bulk equations of state?

We derive a microscopic expression for a quantity $\mu$ that plays the role of chemical potential of Active Brownian Particles (ABPs) in a steady state in the absence of vortices. We show that $\mu$ consists of (i) an intrinsic chemical potential similar to passive systems, which depends on density and self-propulsion speed, but not on the external potential, (ii) the external potential, and (iii) a newly derived one-body swim potential due to the activity of the particles. Our simulations on active Brownian particles show good agreement with our Fokker-Planck calculations, and confirm that $\mu(z)$ is spatially constant for several inhomogeneous active fluids in their steady states in a planar geometry. Finally, we show that phase coexistence of ABPs with a planar interface satisfies not only mechanical but also diffusive equilibrium. The coexistence can be well-described by equating the bulk chemical potential and bulk pressure obtained from bulk simulations for systems with low activity but requires explicit evaluation of the interfacial contributions at high activity.Comment: Added new results in Section 3.4 and updated Discussion and Conclusio

Interparticle torques suppress motility-induced phase separation for rodlike particles

To study the role of torque in motility-induced phase separation (MIPS), we simulate a system of self-propelled particles whose shape varies smoothly from isotropic (disks/spheres) to weakly elongated (rods). We construct the phase diagrams of 2D active disks, 3D active spheres and 2D/3D active rods of aspect ratio $l/\sigma=2$. A stability analysis of the homogeneous isotropic phase allows us to predict the onset of MIPS based on the effective swimming speed and rotational diffusion of the particles. Both methods find suppression of MIPS as the particle shape is elongated. We propose a suppression mechanism based on the duration of collisions, and argue that this mechanism can explain both the suppression of MIPS found here for rodlike particles and the enhancement of MIPS found for particles with Vicsek interactions

Imperfections of the North Atlantic wind-driven ocean circulation: Continental geometry and windstress shape

Multiple equilibria of the wind-driven gyres have been found in idealized quasi-geostrophic and shallow water models. In this paper we demonstrate that multiple equilibria persist within a reduced gravity shallow water model under quite realistic continental geometry and windstress forcing for the North Atlantic. Multiple mean flow patterns of the Gulf Stream exist and differ with respect to their separation behavior along the North American coast. The origin of these equilibria is investigated by determining the structure of steady solutions within a hierarchy of equivalent barotropic ocean models using continuation techniques. Within each model, the magnitude of lateral friction is used as a control parameter. It is shown that symmetry breaking, found in a quasi-geostrophic model for a rectangular ocean basin with idealized wind forcing is at the origin of two different mean states of the Gulf Stream. The steady states found become unstable only to a small number of oscillatory modes, which either have intermonthly or interannual periods. The modes of variability remain strongly related through the hierarchy of models indicating that their physics is not strongly dependent on the shape of the continents but is controlled by internal ocean dynamics

Ratchet-induced variations in bulk states of an active ideal gas

We study the distribution of active, noninteracting particles over two bulk states separated by a ratchet potential. By solving the steady-state Smoluchowski equations in a flux-free setting, we show that the ratchet potential affects the distribution of particles over the bulks, and thus exerts an influence of infinitely long range. As we show, crucial for having such a long-range influence is an external potential that is nonlinear. We characterize how the difference in bulk densities depends on activity and on the ratchet potential, and we identify power law dependencies on system parameters in several limiting cases. While weakly active systems are often understood in terms of an effective temperature, we present an analytical solution that explicitly shows that this is not possible in the current setting. Instead, we rationalize our results by a simple transition state model, that presumes particles to cross the potential barrier by Arrhenius rates modified for activity. While this model does not quantitatively describe the difference in bulk densities for feasible parameter values, it does reproduce - in its regime of applicability - the complete power law behavior correctly.Comment: 11 pages, 6 figure

Analysis and compensation for the effect of the catheter position on image intensities in intravascular optical coherence tomography

Cardiovascular Aspects of Radiolog

Nanomaterials for the Local and Targeted Delivery of Osteoarthritis Drugs

Nanotechnology has found its potential in every possible field of science and engineering. It offers a plethora of options to design tools at the nanometer scale, which can be expected to function more effectively than micro- and macrosystems for specific applications. Although the debate regarding the safety of synthetic nanomaterials for clinical applications endures, it is a promising technology due to its potential to augment current treatments. Various materials such as synthetic polymer, biopolymers, or naturally occurring materials such as proteins and peptides can serve as building blocks for adaptive nanoscale formulations. The choice of materials depends highly on the application. We focus on the use of nanoparticles for the treatment of degenerative cartilage diseases, such as osteoarthritis (OA). Current therapies for OA focus on treating the symptoms rather than modifying the disease. The usefulness of OA disease modifying drugs is hampered by side effects and lack of suitable drug delivery systems that target, deliver, and retain drugs locally. This challenge can be overcome by using nanotechnological formulations. We describe the different nanodrug delivery systems and their potential for cartilage repair. This paper provides the reader basal understanding of nanomaterials and aims at drawing new perspectives on the use of existing nanotechnological formulations for the treatment of osteoarthritis

Prevalence of Monogenic Bone Disorders in a Dutch Cohort of Atypical Femur Fracture Patients

Atypical femur fractures (AFFs), considered rare associations of bisphosphonates, have also been reported in patients with monogenic bone disorders without bisphosphonate use. The exact association between AFFs and monogenic bone disorders remains unknown. Our aim was to determine the prevalence of monogenic bone disorders in a Dutch AFF cohort. AFF patients were recruited from two specialist bone centers in the Netherlands. Medical records of the AFF patients were reviewed for clinical features of monogenic bone disorders. Genetic variants identified by whole-exome sequencing in 37 candidate genes involved in monogenic bone disorders were classified based on the American College of Medical Genetics and Genomics (ACMG) classification guidelines. Copy number variations overlapping the candidate genes were also evaluated using DNA array genotyping data. The cohort comprises 60 AFF patients (including a pair of siblings), with 95% having received bisphosphonates. Fifteen AFF patients (25%) had clinical features of monogenic bone disorders. Eight of them (54%), including the pair of siblings, had a (likely) pathogenic variant in either PLS3, COL1A2, LRP5, or ALPL. One patient carried a likely pathogenic variant in TCIRG1 among patients not suspected of monogenic bone disorders (2%). In total, nine patients in this AFF cohort (15%) had a (likely) pathogenic variant. In one patient, we identified a 12.7 Mb deletion in chromosome 6, encompassing TENT5A. The findings indicate a strong relationship between AFFs and monogenic bone disorders, particularly osteogenesis imperfecta and hypophosphatasia, but mainly in individuals with symptoms of these disorders. The high yield of (likely) pathogenic variants in AFF patients with a clinical suspicion of these disorders stresses the importance of careful clinical evaluation of AFF patients. Although the relevance of bisphosphonate use in this relationship is currently unclear, clinicians should consider these findings in medical management of these patients.</p

Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab- and ustekinumab-treated patients with inflammatory bowel disease-a prospective multicentre cohort study

Background: Few data are available on the effects of age and comorbidity on treatment outcomes of vedolizumab and ustekinumab in inflammatory bowel disease (IBD). Aims: To evaluate the association between age and comorbidity with safety and effectiveness outcomes of vedolizumab and ustekinumab in IBD. Methods: IBD patients initiating vedolizumab or ustekinumab in regular care were enrolled prospectively. Comorbidity prevalence was assessed using the Charlson Comorbidity Index (CCI). Association between age and CCI, both continuously assessed, with safety outcomes (any infection, hospitalisation, adverse events) during treatment, and effectiveness outcomes (clinical response and remission, corticosteroid-free remission, clinical remission combined with biochemical remission) after 52 weeks of treatment were evaluated. Multivariable logistic regression was used to adjust for confounders. Results: We included 203 vedolizumab- and 207 ustekinumab-treated IBD patients, mean age 42.2 (SD 16.0) and 41.6 (SD 14.4). Median treatment duration 54.0 (IQR 19.9-104.0) and 48.4 (IQR 24.4-55.1) weeks, median follow-up time 104.0 (IQR 103.1-104.0) and 52.0 weeks (IQR 49.3-100.4). On vedolizumab, CCI associated independently with any infection (OR 1.387, 95% CI 1.022-1.883, P = 0.036) and hospitalisation (OR 1.586, 95% CI 1.127-2.231, P = 0.008). On ustekinumab, CCI associated independently with hospitalisation (OR 1.621, 95% CI 1.034-2.541, P = 0.035). CCI was not associated with effectiveness, and age was not associated with any outcomes. Conclusions: Comorbidity - but not age - is associated with an increased risk of hospitalisations on either treatment, and with any infection on vedolizumab. This underlines the importance of comorbidity assessment and safety monitoring of IBD patients

Tethering Cells via Enzymatic Oxidative Crosslinking Enables Mechanotransduction in Non-Cell-Adhesive Materials

Cell–matrix interactions govern cell behavior and tissue function by facilitating transduction of biomechanical cues. Engineered tissues often incorporate these interactions by employing cell-adhesive materials. However, using constitutively active cell-adhesive materials impedes control over cell fate and elicits inflammatory responses upon implantation. Here, an alternative cell–material interaction strategy that provides mechanotransducive properties via discrete inducible on-cell crosslinking (DOCKING) of materials, including those that are inherently non-cell-adhesive, is introduced. Specifically, tyramine-functionalized materials are tethered to tyrosines that are naturally present in extracellular protein domains via enzyme-mediated oxidative crosslinking. Temporal control over the stiffness of on-cell tethered 3D microniches reveals that DOCKING uniquely enables lineage programming of stem cells by targeting adhesome-related mechanotransduction pathways acting independently of cell volume changes and spreading. In short, DOCKING represents a bioinspired and cytocompatible cell-tethering strategy that offers new routes to study and engineer cell–material interactions, thereby advancing applications ranging from drug delivery, to cell-based therapy, and cultured meat